Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Rang în acțiuni #33275
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Preț acțiune
$5.39
Capitalizare de piață
$7.87M
Schimbare (1 zi)
-2.45%
Schimbare (1 an)
5.80%
Țară
US
Tranzacționează CNS Pharmaceuticals, Inc. (CNSP)

Categorie

Istoric al prețului acțiunii pentru CNS Pharmaceuticals, Inc. (CNSP)
Cel mai mare preț de închidere: $5.27 pe 2026-08-01

Cel mai mic preț de închidere: $3.79M pe 2019-11-01
Istoric al prețului acțiunii pentru CNS Pharmaceuticals, Inc. din 2019 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -16.53%
2025 -89.84%
2024 -99.87%
2023 -34.43%
2022 -90.86%
2021 -58.90%
2020 -43.49%
2019 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$508.64 29.49%
US
$973.48 48.89%
NL
$733.78 6.78%
CH
$1.07K -6.40%
KR
$254.79 13.07%
BE